サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564035

心臓再同期療法（CRT）機器の世界市場

Cardiac Resynchronization Therapy (CRT) Devices

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
心臓再同期療法（CRT）機器の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓再同期療法（CRT）機器の世界市場は2030年までに109億米ドルに達する見込み

2023年に65億米ドルと推定される心臓再同期療法（CRT）機器の世界市場は、2030年には109億米ドルに達し、分析期間2023-2030年のCAGRは7.7%で成長すると予測されます。本レポートで分析したセグメントの1つであるCRT-除細動器（CRT-D）は、CAGR 7.4%を記録し、分析期間終了時には78億米ドルに達すると予測されます。CRT-ペースメーカー（CRT-P）セグメントの成長率は、分析期間のCAGRで8.4％と推定されます。

米国市場は18億米ドル、中国はCAGR7.3％で成長予測

米国の心臓再同期療法（CRT）機器市場は2023年に18億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに17億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.0％と6.6％と予測されています。欧州では、ドイツがCAGR 7.2%で成長すると予測されています。

世界の心臓再同期療法（CRT）機器市場- 主要動向と促進要因のまとめ

心臓再同期療法（CRT）機器とは何か、なぜ必要なのか？

心臓再同期療法（CRT）機器は、心不全の管理、特に心臓の効率的な拍動能力を損なう電気伝導障害を患う患者にとって重要なツールです。これらのデバイスは、心臓の心室の協調収縮を回復させ、全体的なポンプ効率を改善するように設計されています。CRT装置は通常、ペースメーカーまたは植え込み型除細動器（ICD）で構成され、心臓の両心室に設置されるリード線を備えています。心室に同期した電気パルスを送ることで、CRT装置は心不全や脚ブロックの患者によくみられる心拍のずれを修正します。この治療法は、中等度から重度の心不全で、従来の治療法では効果が不十分な患者に処方されることが多いです。CRTの最終的な目標は、息切れや疲労などの心不全症状を軽減し、生活の質を改善し、入院や死亡のリスクを低下させることです。心不全は世界中で何百万人もの人々に影響を及ぼしており、CRT装置はこの慢性的でしばしば衰弱させる疾患の管理における重要な介入となります。

CRTデバイスの有効性を高める技術は？

CRTデバイスの技術的な進化は、その有効性、安全性、および患者の全体的な体験を著しく向上させています。この分野における主な進歩のひとつは、患者の活動レベルや心臓のリズムに基づいてペーシングを自動的に調整する適応型CRTシステムの開発です。これらのシステムは、安静時や運動時などさまざまな条件下で、心臓の拍動を可能な限り効率的にすることで、治療を最適化する高度なアルゴリズムを利用しています。もうひとつの大きな技術革新は、患者データをヘルスケア・プロバイダーにリアルタイムでトランスミッションできる、リモート・モニタリング機能の統合です。これにより、臨床医は、頻繁に訪問することなく、装置の性能と患者の心臓の状態を継続的にモニターすることができます。遠隔監視は、治療のタイムリーな調整を通じて患者の予後を改善するだけでなく、入院や緊急介入の必要性を減らします。さらに、CRT装置の小型化により、侵襲が少なくなり、患者にとってより快適なものとなった。これらの小型で効率的な装置は、バッテリーの寿命が長くなり、埋め込みが容易になったため、手術中の合併症のリスクが減少しました。CRT装置にワイヤレス技術が搭載されたことで、装置と外部モニタリングシステムとのシームレスな通信が可能になり、患者ケアはさらに向上しました。技術の進歩に伴い、心不全治療におけるCRTデバイスの精度と有効性は向上し、患者にとってより良い治療結果がもたらされることが期待されます。

心臓再同期療法機器の主な市場動向は？

心臓再同期療法機器市場は、テクノロジーの進歩、人口動態の変化、ヘルスケア提供の変化によって形成されたいくつかの重要な動向が牽引しています。最も注目すべき動向の1つは、世界的に心不全の有病率が増加していることです。これは、人口の高齢化や高血圧、糖尿病、冠動脈疾患など、心不全の発症に関与する疾患の発生率が上昇していることが主な原因です。このため、薬物療法だけでは効果が得られない患者の治療オプションとして、CRT装置の需要が高まっています。もう一つの主要動向は、遠隔患者モニタリング・ソリューションの採用が拡大していることです。ヘルスケア・システムのデジタル・プラットフォーム化が進む中、遠隔モニタリング機能を備えたCRTデバイスの普及が進んでいます。これは患者管理を向上させるだけでなく、遠隔医療や在宅医療を目指す世界の動向とも一致しています。さらに、CRTデバイスの小型化とリードレスバージョンの開拓が進んでおり、デバイスの低侵襲化とリードに関連する合併症の可能性の低減により、市場に革命をもたらそうとしています。特に北米や欧州のような先進地域では、救命技術をより早く患者に届けるために規制当局がプロセスを合理化しており、こうした革新的な機器の規制当局による承認が加速しています。最後に、いくつかの地域におけるヘルスケア保険適用と償還政策の拡大により、CRTデバイスがより多くの患者にとって利用しやすくなり、普及が進んでいます。

CRTデバイス市場の拡大要因は何か？

心臓再同期療法機器市場の成長は、技術の進歩、ヘルスケア動向の変化、患者層の変化に関連するいくつかの重要な要因によって牽引されています。主な促進要因は、世界全体で心不全の有病率が上昇していること、特に高齢化が進んでいることです。心不全患者数が増加し続けるにつれて、CRTのような効果的な治療オプションに対する需要も増加しており、これは従来の心不全治療に反応しない患者にとって特に重要です。適応型CRTデバイスの開発や遠隔モニタリング機能の統合など、CRT技術の進歩が続いているため、これらのデバイスの魅力は著しく高まっています。患者固有のニーズに基づいてペーシングパラメータを自動的に調整する適応システムは、治療効果を向上させ、合併症の可能性を減少させる。さらに、遠隔医療と遠隔患者モニタリングの普及が、データをシームレスに送信できるCRTデバイスの需要を押し上げ、心不全患者のより積極的で効率的な管理を可能にしています。COVID-19の流行によってさらに加速した在宅医療へのシフトは、慢性疾患管理における遠隔モニタリングの重要性を強調しています。また、再入院の減少や長期予後の改善にますます焦点が当てられるようになり、ヘルスケアシステムがバリュー・ベース・ケア・モデルを採用するようになったことも、もう一つの推進力となっています。心機能を改善し、緊急介入の必要性を減らすCRTは、こうしたヘルスケアの目標に合致しています。さらに、機器の小型化とバッテリー寿命の向上により、CRT機器はより利用しやすく、侵襲性が低く、耐久性に優れているため、患者の満足度が高まり、全体的な普及率が向上しています。最後に、特に新興国市場において、有利な規制政策と医療保険の拡大が、患者の救命機器へのアクセスを容易にし、市場の成長をさらに後押ししています。

調査対象企業の例（注目の42社）

  • Abbott Cardiovascular
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medico SpA
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Osypka Medical GmbH

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10899

Global Cardiac Resynchronization Therapy (CRT) Devices Market to Reach US$10.9 Billion by 2030

The global market for Cardiac Resynchronization Therapy (CRT) Devices estimated at US$6.5 Billion in the year 2023, is expected to reach US$10.9 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. CRT-Defibrillator (CRT-D), one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the CRT-Pacemaker (CRT-P) segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 7.3% CAGR

The Cardiac Resynchronization Therapy (CRT) Devices market in the U.S. is estimated at US$1.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Cardiac Resynchronization Therapy (CRT) Devices Market - Key Trends and Drivers Summarized

What Are Cardiac Resynchronization Therapy (CRT) Devices and Why Are They Essential?

Cardiac Resynchronization Therapy (CRT) devices are critical tools in the management of heart failure, particularly for patients suffering from electrical conduction problems that impair the heart’s ability to beat efficiently. These devices are designed to restore the coordinated contraction of the heart's ventricles, improving its overall pumping efficiency. CRT devices typically consist of a pacemaker or an implantable cardioverter-defibrillator (ICD) equipped with leads that are placed in both ventricles of the heart. By delivering synchronized electrical pulses to the ventricles, CRT devices correct the misalignment in heartbeats that is common in patients with heart failure or bundle branch block. This form of therapy is often prescribed for individuals who have moderate to severe heart failure and who have not responded well to conventional treatments. The ultimate goal of CRT is to reduce the symptoms of heart failure, such as shortness of breath and fatigue, improve the quality of life, and lower the risk of hospitalization or death. With heart failure affecting millions of people worldwide, CRT devices represent a vital intervention in the management of this chronic and often debilitating condition.

How Is Technology Enhancing the Effectiveness of CRT Devices?

The technological evolution of CRT devices has significantly enhanced their effectiveness, safety, and the overall patient experience. One of the key advancements in this field has been the development of adaptive CRT systems that automatically adjust pacing based on a patient’s activity levels and heart rhythms. These systems utilize sophisticated algorithms to optimize therapy by ensuring the heart beats as efficiently as possible under various conditions, such as rest or exercise. Another major innovation is the integration of remote monitoring capabilities, allowing real-time transmission of patient data to healthcare providers. This enables clinicians to continuously monitor the performance of the device and the patient's heart condition without the need for frequent in-person visits. Remote monitoring not only improves patient outcomes through timely adjustments in therapy but also reduces the need for hospitalizations and emergency interventions. Additionally, the miniaturization of CRT devices has made them less invasive and more comfortable for patients. These smaller, more efficient devices now have longer battery lives and are easier to implant, reducing the risk of complications during surgery. The inclusion of wireless technology in CRT devices has further improved patient care, allowing for seamless communication between the device and external monitoring systems. As technology continues to advance, the precision and efficacy of CRT devices in treating heart failure are expected to grow, offering even better outcomes for patients.

What Are the Key Market Trends in Cardiac Resynchronization Therapy Devices?

Several important trends are driving the cardiac resynchronization therapy devices market, shaped by advancements in technology, demographic shifts, and changes in healthcare delivery. One of the most notable trends is the increasing prevalence of heart failure globally, largely driven by aging populations and the rising incidence of conditions such as hypertension, diabetes, and coronary artery disease, all of which contribute to the onset of heart failure. This has fueled the demand for CRT devices as a treatment option for patients who are not responding to medications alone. Another key trend is the growing adoption of remote patient monitoring solutions. With healthcare systems increasingly moving towards digital platforms, CRT devices with remote monitoring capabilities are becoming more widespread. This not only improves patient management but also aligns with the global trend towards telemedicine and home-based care. Furthermore, the ongoing miniaturization of CRT devices and the development of leadless versions are set to revolutionize the market by making the devices less invasive and reducing the potential for lead-related complications. Regulatory approval of these innovative devices is accelerating, particularly in developed regions like North America and Europe, where regulatory agencies have streamlined processes to get these life-saving technologies to patients faster. Lastly, the expansion of healthcare coverage and reimbursement policies in several regions is making CRT devices more accessible to a broader patient population, driving increased adoption.

What Are the Factors Driving Expansion of the CRT Devices Market?

The growth in the cardiac resynchronization therapy devices market is driven by several key factors tied to advancements in technology, shifts in healthcare trends, and changing patient demographics. A primary driver is the rising prevalence of heart failure across the globe, particularly in aging populations. As the number of heart failure patients continues to increase, so does the demand for effective treatment options like CRT, which is especially critical for patients who do not respond to conventional heart failure therapies. The ongoing advancements in CRT technology, such as the development of adaptive CRT devices and the integration of remote monitoring capabilities, have significantly enhanced the appeal of these devices. Adaptive systems that automatically adjust pacing parameters based on patient-specific needs improve therapy effectiveness and reduce the likelihood of complications. Moreover, the widespread adoption of telemedicine and remote patient monitoring has boosted the demand for CRT devices that can seamlessly transmit data, allowing for more proactive and efficient management of heart failure patients. The shift toward home-based care, further accelerated by the COVID-19 pandemic, has emphasized the importance of remote monitoring in chronic disease management. Another driver is the increasing focus on reducing hospital readmissions and improving long-term outcomes, which has led healthcare systems to embrace value-based care models. CRT devices, by improving heart function and reducing the need for emergency interventions, align well with these healthcare goals. Additionally, advancements in device miniaturization and battery life are making CRT devices more accessible, less invasive, and more durable, leading to higher patient satisfaction and better overall adoption. Finally, favorable regulatory policies and expanding healthcare coverage, especially in developed markets, have made it easier for patients to access these life-saving devices, further fueling market growth.

Select Competitors (Total 42 Featured) -

  • Abbott Cardiovascular
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medico SpA
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Osypka Medical GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiac Resynchronization Therapy (CRT) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Heart Failure Throws the Spotlight on Cardiac Resynchronization Therapy (CRT) Devices
    • Technological Advancements in CRT Devices Propel Growth in Heart Failure Treatment
    • Increasing Use of Remote Monitoring Expands Addressable Market Opportunity for CRT Devices
    • Growing Adoption of AI in Health Monitoring Spurs Demand for Smarter CRT Devices
    • Integration of Telemedicine Generates New Opportunities for CRT Device Management
    • Expanding Use of Advanced Imaging Techniques Drives Precision in CRT Device Implantation
    • Rising Demand for Non-Invasive Monitoring Propels Growth in CRT Device Usage
    • Innovations in Battery Longevity and Device Miniaturization Accelerate Demand for Next-Generation CRT Devices
    • Increasing Need for Long-Term, Real-Time Monitoring Spurs Use of Advanced CRT Devices
    • Advancements in Device Connectivity and Data Analytics Propel Growth of CRT Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Resynchronization Therapy (CRT) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for CRT-Defibrillator (CRT-D) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for CRT-Pacemaker (CRT-P) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION